NO176868C - Fremgangsmåte ved fremstilling av et fast syrenöytraliserende preparat med forlenget oppholdstid i mavesekken - Google Patents

Fremgangsmåte ved fremstilling av et fast syrenöytraliserende preparat med forlenget oppholdstid i mavesekken

Info

Publication number
NO176868C
NO176868C NO891641A NO891641A NO176868C NO 176868 C NO176868 C NO 176868C NO 891641 A NO891641 A NO 891641A NO 891641 A NO891641 A NO 891641A NO 176868 C NO176868 C NO 176868C
Authority
NO
Norway
Prior art keywords
preparation
residence time
stomach
solid acid
acid neutralizing
Prior art date
Application number
NO891641A
Other languages
English (en)
Norwegian (no)
Other versions
NO176868B (no
NO891641D0 (no
NO891641L (no
Inventor
Robert G W Spickett
Jose Luis Fabregas Vidal
Juan Cuala Escoi
Original Assignee
Walton Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walton Sa filed Critical Walton Sa
Publication of NO891641D0 publication Critical patent/NO891641D0/no
Publication of NO891641L publication Critical patent/NO891641L/no
Publication of NO176868B publication Critical patent/NO176868B/no
Publication of NO176868C publication Critical patent/NO176868C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
NO891641A 1988-04-21 1989-04-20 Fremgangsmåte ved fremstilling av et fast syrenöytraliserende preparat med forlenget oppholdstid i mavesekken NO176868C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888809421A GB8809421D0 (en) 1988-04-21 1988-04-21 Antacid compositions with prolonged gastric residence time

Publications (4)

Publication Number Publication Date
NO891641D0 NO891641D0 (no) 1989-04-20
NO891641L NO891641L (no) 1989-10-23
NO176868B NO176868B (no) 1995-03-06
NO176868C true NO176868C (no) 1995-06-14

Family

ID=10635574

Family Applications (1)

Application Number Title Priority Date Filing Date
NO891641A NO176868C (no) 1988-04-21 1989-04-20 Fremgangsmåte ved fremstilling av et fast syrenöytraliserende preparat med forlenget oppholdstid i mavesekken

Country Status (19)

Country Link
US (1) US5288506A (fr)
EP (1) EP0338861B1 (fr)
JP (1) JPH0764724B2 (fr)
KR (1) KR950007205B1 (fr)
AT (1) ATE84708T1 (fr)
AU (1) AU616257B2 (fr)
CA (1) CA1336495C (fr)
DE (1) DE68904459T2 (fr)
DK (1) DK188489A (fr)
ES (1) ES2044099T3 (fr)
FI (1) FI98886C (fr)
GB (1) GB8809421D0 (fr)
GR (1) GR3006908T3 (fr)
HU (1) HU211236A9 (fr)
IE (1) IE61866B1 (fr)
NO (1) NO176868C (fr)
NZ (1) NZ228836A (fr)
PT (1) PT90328B (fr)
ZA (1) ZA892920B (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK121193A3 (en) * 1991-04-04 1994-07-06 Procter & Gamble Chewable antacid compositions
FR2677546B1 (fr) * 1991-06-12 1994-01-21 Fabienne Joanny Composition therapeutique pour liberation prolonge de magnesium.
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
DE4415999A1 (de) * 1994-05-06 1995-11-09 Bolder Arzneimittel Gmbh Magensäurebindende Kaupastillen
JP2683454B2 (ja) * 1994-06-06 1997-11-26 山之内製薬株式会社 固形制酸剤及びその製造法
US6306828B1 (en) * 1995-04-06 2001-10-23 Baxter International, Inc. Enantiomerically-enhanced nutritional energy substrates
EP0867191A4 (fr) * 1995-11-27 2000-01-05 Yamanouchi Pharma Co Ltd Composition de medicament
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
SE9600071D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
FR2793688B1 (fr) * 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
DE60020716T2 (de) 1999-07-22 2005-12-15 Warner-Lambert Co. Llc Filmbildende zusammensetzungen aus pullulan
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
EP1245227A1 (fr) * 2001-03-31 2002-10-02 Jagotec Ag Comprimé pharmaceutique flottant dans l'estomac destiné à la libération programmée du principe actif et procédé pour produire le matériel flottant compris dans le comprimé
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
WO2003063840A2 (fr) * 2002-01-25 2003-08-07 Santarus, Inc. Administration par voie muqueuse d'inhibiteurs de la pompe a protons
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
WO2004073654A2 (fr) * 2003-02-20 2004-09-02 Santarus, Inc. Liberation immediate d'un complexe antacide d'omeprazole presentant une nouvelle formulation pour une elimination rapide et prolongee d'acide gastrique
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
MXPA06000524A (es) * 2003-07-18 2006-08-11 Santarus Inc Formulacion farmaceutica y metodo para tratar desordenes gastrointestinales provocados por acido.
CA2531564C (fr) * 2003-07-18 2016-01-19 Santarus, Inc. Formulations pharmaceutiques utilisees pour inhiber une secretion acide et procede de fabrication associe
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP2006131581A (ja) * 2004-11-09 2006-05-25 Kyowa Chem Ind Co Ltd 崩壊剤及びこれを含有する崩壊性成形物
CA2654402A1 (fr) * 2006-06-01 2007-12-06 Adel Penhasi Formulation pharmaceutique comprenant des unites multiples
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
ES2536836T3 (es) 2012-10-12 2015-05-29 Omya International Ag Formulación de medicamento gastrorretentivo y sistemas de liberación y su método de preparación usando carbonato de calcio transformado en funcional
EP3034070A1 (fr) 2014-12-18 2016-06-22 Omya International AG Procédé pour la production d'un système d'administration pharmaceutique
EP3069713A1 (fr) 2015-03-20 2016-09-21 Omya International AG Forme posologique dispersible
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
CA2898600A1 (fr) * 2015-07-28 2017-01-28 Jayson King Appareil de confinement de boite a garniture
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
EP3269361A1 (fr) 2016-07-14 2018-01-17 Omya International AG Forme posologique
CN110327370B (zh) * 2019-04-16 2021-02-23 马德君 阴离子黏土用于制备驱铅药物的用途
CN110780063A (zh) * 2019-12-10 2020-02-11 无锡市尚沃医疗电子股份有限公司 一种呼气氨检测方法和装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1416304A (fr) * 1961-10-10 1965-11-05 Smith Kline French Lab Perfectionnements apportés aux tablettes et comprimés renfermant une importante quantité d'ingrédient actif libéré pendant un laps de temps prolongé, et aux procédés pour leur préparation
CA948107A (en) * 1970-04-28 1974-05-28 Robert S. Joslin Coated antacid compositions of improved taste
US4101650A (en) * 1977-04-06 1978-07-18 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Pepstatin floating minicapsules
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
MTP930B (en) * 1982-04-30 1984-04-10 Delandale Labs Ltd Substained release lithium-containing tablets and method for their manufacture
US4605551A (en) * 1984-11-30 1986-08-12 William H. Rorer, Inc. Dry oil coated antacid process
US4778676A (en) * 1985-12-20 1988-10-18 Warner-Lambert Company Confectionery delivery system for actives
JPS62195323A (ja) * 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
CH674148A5 (fr) * 1986-06-24 1990-05-15 Racz Istvan

Also Published As

Publication number Publication date
EP0338861A3 (en) 1990-09-19
IE61866B1 (en) 1994-11-30
JPH0215025A (ja) 1990-01-18
EP0338861A2 (fr) 1989-10-25
PT90328B (pt) 1994-11-30
FI98886B (fi) 1997-05-30
PT90328A (pt) 1989-11-10
KR890015733A (ko) 1989-11-25
NO176868B (no) 1995-03-06
IE891282L (en) 1989-10-21
FI891896L (fi) 1989-10-22
AU3317589A (en) 1989-10-26
ZA892920B (en) 1989-12-27
NO891641D0 (no) 1989-04-20
NO891641L (no) 1989-10-23
US5288506A (en) 1994-02-22
DK188489A (da) 1989-10-23
ATE84708T1 (de) 1993-02-15
EP0338861B1 (fr) 1993-01-20
CA1336495C (fr) 1995-08-01
ES2044099T3 (es) 1994-01-01
DE68904459T2 (de) 1993-05-13
DK188489D0 (da) 1989-04-19
DE68904459D1 (de) 1993-03-04
GR3006908T3 (fr) 1993-06-30
JPH0764724B2 (ja) 1995-07-12
KR950007205B1 (ko) 1995-07-04
FI98886C (fi) 1997-09-10
AU616257B2 (en) 1991-10-24
HU211236A9 (en) 1995-11-28
FI891896A0 (fi) 1989-04-20
NZ228836A (en) 1990-09-26
GB8809421D0 (en) 1988-05-25

Similar Documents

Publication Publication Date Title
NO176868C (no) Fremgangsmåte ved fremstilling av et fast syrenöytraliserende preparat med forlenget oppholdstid i mavesekken
ATE74513T1 (de) Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen.
PT89260A (pt) Processo de preparacao de uma composicao farmaceutica granular a base de cimetidina e de comprimidos a partir daquela
AU582920B2 (en) Continuous release pharmaceutical compositions
DK0449247T3 (da) Farmaceutisk formulering indeholdende galanthamin til behandling af alkoholisme
ES2041699T3 (es) Procedimiento de preparacion de un medicamento a base de fenofibrato y medicamento obtenido por este procedimiento.
NO176232C (no) Fremgangsmåte for fremstilling av en fast, oral doseringsform med regulert frigivelse av medikament
DE68915695D1 (de) Zubereitungen mit kontrollierter Wirkstoffabgabe.
ZA873299B (en) Formulations containing unsaturated fatty acids for the synthesis of prostablandins and hydroxy-fatty acids in biological systems
ATE79538T1 (de) Dispergierbare zubereitung.
ATE21336T1 (de) Galenische form zur oralen verabreichung und verfahren zu deren herstellung.
ES2018952A6 (es) Procedimiento de preparacion de composiciones antiacidas con tiempo prolongado de permanencia gastrica.
NO177484C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat i form av myke kapsler
MX10146A (es) Procedimiento para la produccion de preparados medicinales que contienen y liberan sustancias activas y producto obtenido.
IL86169A (en) Substituted quinoxalyl-imidazolidine-2,4-diones,processes for their preparation and pharmaceutical compositions containing them
JPS57193473A (en) Vitamin e linoleic acid ester
JPS5668672A (en) Novel 2-acetoxybenzamide derviative, its preparation, and pharmaceutical containing said derviative as effective component
JPS5626910A (en) Preparation of slow-release anticancer complex composition
JPS5392768A (en) Cyclopropanecarboxylic acid esters, process for their preparation and insecticides and miticides containing the same
JPS5340761A (en) Preparation of unsaturated imide amides
NO174346C (no) Fremgangsmåte for fremstilling av 5-aroyl-1,2-dihydro-3H-pyrrolo-(1,2-a)-pyrrol-1-carboxylsyrer og alkylestere og salter derav
DK637187D0 (da) Praeparat med reguleret frigivelse af virksomme komponenter til inkorporering i et tyggeligt produkt til fremstilling af praeparatet